RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

110 hedge funds and large institutions have $854M invested in Revance Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 13 closing their positions.

Holders
110
Holders Change
Holders Change %
0%
% of All Funds
2.52%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
13
Increased
33
Reduced
29
Closed
13
Calls
$2.08M
Puts
$1.94M
Net Calls
+$139K
Net Calls Change
-$607K
Name Market Value Shares Shares
Change
Shares
Change %
CFGS
126
Concourse Financial Group Securities
Alabama